BIO-PATH HOLDINGS, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
4710 BELLAIRE BOULEVARD, BELLAIRE, TX, 77401
Mailing Address
4710 BELLAIRE BOULEVARD, BELLAIRE, TX, 77401
Phone
(832) 742-1357
Fiscal Year End
1231
EIN
870652870
Financial Overview
FY2024
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 20, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 13, 2026 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 29, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
| 8-K Current report of material events | August 13, 2025 | View on SEC |
| 8-K Current report of material events | June 24, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | May 15, 2025 | View on SEC |
Material Events
8-K
Financial Distress
February 24, 2026
High Impact
- CEO Vikram Grover, via Steel Giants Advisors LLC (SGA), secured 51% of voting power for $10,000, consolidating control for a turnaround.
- Company aims to restart crucial Phase 1 and Phase 2 drug trials (AML, solid tumors, obesity) after halting them due to financial strain.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.